A study on dogs, conducted by researchers at the University of California, Davis, has found human immune proteins to be moderately successful in controlling lung cancers without causing major sensitivities and toxicities, showing potential for the protein’s use in humans. Surgical oncologist Dr. Robert J. Canter and canine oncologist Robert B. Rebhun co-authored the study, along with scientists from other institutions.
The study was published in the Journal for ImmunoTherapy of Cancer, an open-access, peer-reviewed journal, on June 9.
